Copyright
©The Author(s) 2021.
World J Methodol. Jul 20, 2021; 11(4): 187-198
Published online Jul 20, 2021. doi: 10.5662/wjm.v11.i4.187
Published online Jul 20, 2021. doi: 10.5662/wjm.v11.i4.187
Intervention | Clinical parameters evaluated | |||||||||
Study | Creatinine (mg/dL) | Change in BUN (mg/dL) | GFR (mL/min per 1.73 m2) | Weight loss (Ib) | Urine output (mL/d) | |||||
Baseline | Mean changes | Baseline | Mean changes | Mean changes | Baseline | Mean changes | Baseline | Mean changes | ||
Ultrafiltration | Bart et al[11], 2012 | 2.09 | -0.04 ± 0.53 | 50.5 | 5.68 ± 18.29 | 1.67 ± 10.94 | 234 | 12.1 ± 11.3 | NA | NA |
Bart et al[11], 2012 (pharmaco-logic therapy) | 1.90 | +0.23 ± 0.70 | 48.7 | 12.54 ± 24.81 | 0.93 ± 14.60 | 207 | 12.6 ± 8.5 | NA | NA |
- Citation: Ong LT. Evidence based review of management of cardiorenal syndrome type 1. World J Methodol 2021; 11(4): 187-198
- URL: https://www.wjgnet.com/2222-0682/full/v11/i4/187.htm
- DOI: https://dx.doi.org/10.5662/wjm.v11.i4.187